ASKA Pharmaceutical Holdings Co.,Ltd. [4886]: Company Information (Fiscal Year-End, Representative's Name, Major Shareholders, IR Videos, etc.)

The story

ASKA Pharmaceutical Holdings has announced 4 November 2026 as its scheduled earnings announcement date, and earnings-related disclosures are expected to be released.

The latest update on the company’s substantial shareholdings was dated 8 April 2026 and stated that Nippon Active Value Fund (NIPPONACTIVEVALUEFUNDPLC) held an 8.34% stake. The number of shares held was 2,399,100.

The history of previous changes in the fund’s holdings shows that its stake was 8.22% on 28 March 2025 and 8.34% on 13 May 2025.

At a glance

Financial results dateScheduled earnings announcement: 2026/11/4

Major shareholdersNIPPONACTIVEVALUEFUNDPLC holds 8.34% (as of 2026/04/08)

Shares held2,399,100 shares (as of 2026/04/08)

Historical trendChanged to 8.34% on 2025/05/13 and 8.22% on 2025/03/28 (Nippon Active Value Fund in both cases)

Reference information. Every claim resolves to something the story actually named.

Where this came from

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

finance.yahoo.co.jpNews

PrimaryOpen

Read the original articleGo to the source page

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.